Neoadjuvant Herceptin recommended for locally advanced breast cancer

29 January 2010 | by Tony James Print this article Comments Share this article
Adding neoadjuvant trastuzumab to chemotherapy should be considered in women with HER2-positive locally advanced breast cancer, the European NOAH trial has concluded....

Want to read complete article? Please Sign in or Register.

Journals

Members of Oncology Update can access the following journals for free:

Most viewed articles this week

Recent comments

Related sites